Skip to main content
The Markets by Proactive
Go to Proactive Australia

Pharma & Biotech

Poolbeg Pharma appoints infectious disease expert to scientific advisory board

Professor Daniel Hoft has 32 years of experience and has published over 140 peer-reviewed articles

Poolbeg Pharma PLC (AIM:POLB) appointed a new member to its scientific advisory board.

Professor Daniel Hoft is the Dianna and J. Joseph Adorjan Endowed Chair of Infectious Diseases and Immunology, and Director of the Division of Infectious Diseases, Allergy & Immunology at Saint Louis University School of Medicine.

He has been working in immunology and infectious diseases for 32 years and has published over 140 peer-reviewed scientific publications.

He will sit on the advisory board alongside Dr Elaine Sullivan and Professor Luke O’Neill.